HYDROFLUMETHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydroflumethiazide, and when can generic versions of Hydroflumethiazide launch?
Hydroflumethiazide is a drug marketed by Par Pharm, Watson Labs, and Usl Pharma. and is included in six NDAs.
The generic ingredient in HYDROFLUMETHIAZIDE is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROFLUMETHIAZIDE?
- What are the global sales for HYDROFLUMETHIAZIDE?
- What is Average Wholesale Price for HYDROFLUMETHIAZIDE?
Summary for HYDROFLUMETHIAZIDE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,809 |
| DailyMed Link: | HYDROFLUMETHIAZIDE at DailyMed |
Recent Clinical Trials for HYDROFLUMETHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Pfizer |
Medical Subject Heading (MeSH) Categories for HYDROFLUMETHIAZIDE
Anatomical Therapeutic Chemical (ATC) Classes for HYDROFLUMETHIAZIDE
US Patents and Regulatory Information for HYDROFLUMETHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | HYDROFLUMETHIAZIDE | hydroflumethiazide | TABLET;ORAL | 088850-001 | May 31, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Usl Pharma | HYDROFLUMETHIAZIDE AND RESERPINE | hydroflumethiazide; reserpine | TABLET;ORAL | 088195-001 | Oct 26, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | HYDROFLUMETHIAZIDE | hydroflumethiazide | TABLET;ORAL | 088031-001 | Apr 6, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | HYDROFLUMETHIAZIDE | hydroflumethiazide | TABLET;ORAL | 088528-001 | Aug 15, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | HYDROFLUMETHIAZIDE AND RESERPINE | hydroflumethiazide; reserpine | TABLET;ORAL | 088110-001 | Mar 22, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | HYDROFLUMETHIAZIDE AND RESERPINE | hydroflumethiazide; reserpine | TABLET;ORAL | 088127-001 | Mar 22, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
